title: Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations?
abstract: Nanoparticles (NP) absorbed in the body will come in contact with blood proteins and form NP/protein complexes termed protein coronas, which may modulate NP cellular uptake. This study quantitated human epidermal keratinocyte (HEK) uptake of silver (Ag) NP complexed to different human serum proteins. Prior to HEK dosing, AgNP (20nm and 110nm citrate BioPure™; 40nm and 120nm silica-coated) were preincubated for 2h at 37°C without (control) or with physiological levels of albumin (44mg/ml), IgG (14.5mg/ml) or transferrin (3mg/ml) to form protein-complexed NP. HEK were exposed to the protein incubated AgNP for 3h, rinsed and incubated for 24h, rinsed in buffer and lysed. Ag was assayed by inductively-coupled plasma optical emission spectrometry. Uptake of Ag in HEK was <4.1% of applied dose with proteins suppressing citrate, but not silica coated Ag uptake. IgG exposure dramatically reduced 110nm citrate AgNP uptake. In contrast, greatest uptake of 20nm silica AgNP was seen with IgG, while 110nm silica AgNP showed minimal protein effects. Electron microscopy confirmed cellular uptake of all NP but showed differences in the appearance and agglomeration state of the NP within HEK vacuoles. This work suggests that NP association with different serum proteins, purportedly forming different protein coronas, significantly modulates Ag uptake into HEK compared to native NP uptake, suggesting caution in extrapolating in vitro uptake data to predict behavior in vivo where the nature of the protein corona may determine patterns of cellular uptake, and thus biodistribution, biological activity and toxicity.
authors: Nanotechnology Innovation Center of Kansas State, Kansas State University, Manhattan, KS, USA. nmonteiro@ksu.edu
authors: Nancy A
authors: NA
authors: Monteiro-Riviere
authors: Meghan E
authors: ME
authors: Samberg
authors: Steven J
authors: SJ
authors: Oldenburg
authors: Jim E
authors: JE
authors: Riviere
mesh_terms: D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism*; D015603:Keratinocytes / Q000378:metabolism*; D053768:Metal Nanoparticles / Q000737:chemistry*; D046529:Microscopy, Electron, Transmission; D011485:Protein Binding; D012709:Serum Albumin / Q000378:metabolism*; D012834:Silver / Q000378:metabolism*; D014168:Transferrin / Q000378:metabolism*
chemical_list: D007074:Immunoglobulin G; D012709:Serum Albumin; D014168:Transferrin; D012834:Silver
references: Nat Nanotechnol. 2013 Feb;8(2):137-43
references: 23334168
references: Chem Soc Rev. 2012 Apr 7;41(7):2780-99
references: 22086677
references: Biomacromolecules. 2007 Mar;8(3):793-9
references: 17309294
references: J Invest Dermatol. 2007 Jan;127(1):143-53
references: 16902417
references: Arch Pathol Lab Med. 1976 Aug;100(8):405-14
references: 60092
references: Nat Nanotechnol. 2012 Dec;7(12):779-86
references: 23212421
references: J Appl Toxicol. 2010 Apr;30(3):276-85
references: 20013751
references: Small. 2013 Jun 24;9(12):2171-81
references: 23322550
references: Toxicol Lett. 2005 Mar 15;155(3):377-84
references: 15649621
references: Nat Mater. 2009 Jul;8(7):543-57
references: 19525947
references: Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2050-5
references: 17267609
references: Nat Nanotechnol. 2010 Sep;5(9):671-5
references: 20711178
references: Toxicol Appl Pharmacol. 2008 Apr 15;228(2):200-11
references: 18261754
references: Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14265-70
references: 18809927
references: Biomaterials. 2011 Dec;32(35):9353-63
references: 21911254
references: ACS Nano. 2012 Oct 23;6(10):8962-9
references: 22998416
references: Toxicol In Vitro. 2011 Dec;25(8):2105-12
references: 21964474
references: J Appl Toxicol. 2012 Nov;32(11):913-9
references: 22760951
references: Toxicol Appl Pharmacol. 2009 Jan 15;234(2):222-35
references: 18983864
references: Environ Health Perspect. 2010 Mar;118(3):407-13
references: 20064793
references: Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009 Jan-Feb;1(1):26-34
references: 20049776
references: Int J Toxicol. 2007 Mar-Apr;26(2):103-13
references: 17454250
references: ACS Nano. 2012 Jul 24;6(7):5845-57
references: 22721453
references: Nanotoxicology. 2011 Jun;5(2):244-53
references: 21034371
references: Adv Colloid Interface Sci. 2007 Oct 31;134-135:167-74
references: 17574200
references: PLoS One. 2010 Jun 03;5(6):e10949
references: 20532175
references: Nano Lett. 2007 Jun;7(6):1542-50
references: 17465586
references: PLoS One. 2013 May 31;8(5):e64690
references: 23741371
references: Nanomedicine (Lond). 2012 Aug;7(8):1197-209
references: 22583572
references: J Am Chem Soc. 2011 Mar 2;133(8):2525-34
references: 21288025
references: Nano Lett. 2007 May;7(5):1344-8
references: 17408303
references: ACS Nano. 2012 Nov 27;6(11):9887-99
references: 23046098
references: ACS Nano. 2011 Mar 22;5(3):1657-69
references: 21344890